Stroke Treatment Market Analysis By Manufacturers, Regions, Types and Applications 2027

0
2K

The stroke treatment market focuses on addressing the urgent medical needs of individuals affected by stroke, a leading cause of disability and mortality worldwide. Stroke, characterized by the sudden interruption of blood flow to the brain, requires prompt medical intervention to minimize brain damage and improve outcomes. The market encompasses a range of therapeutic interventions aimed at acute stroke management, secondary prevention, neurorehabilitation, and long-term care for stroke survivors.

Stroke Treatment market is estimated to attain a valuation of ~US$ 4.2 billion by the end of 2027, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of ~7% during the forecast period, 2019-2027

Get a Sample Copy of the Stroke Treatment Market Research Report –https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=73917

The significant players operating in the global Stroke Treatment market are- Bristol-Myers Squibb Company, Sanofi, Johnson & Johnson Services, Inc., Boehringer Ingelheim GmbH, F. Hoffmann-La Roche (Genentech)

Key Drivers:

  1. High Global Disease Burden: Stroke is a major public health concern globally, contributing to significant morbidity, mortality, and healthcare costs. The growing prevalence of stroke risk factors such as hypertension, diabetes, and aging populations underscores the need for effective stroke treatment strategies to address this burgeoning healthcare challenge.
  2. Advancements in Acute Stroke Care: Recent advancements in acute stroke care, including the widespread adoption of intravenous thrombolysis with tissue plasminogen activator (tPA) and endovascular thrombectomy for large vessel occlusion, have revolutionized acute stroke management, leading to improved outcomes and reduced disability in select patient populations.
  3. Focus on Secondary Prevention: Secondary prevention strategies play a crucial role in reducing the risk of recurrent stroke and improving long-term outcomes in stroke survivors. Pharmacological interventions, lifestyle modifications, and risk factor control are key components of secondary stroke prevention efforts, driving demand for effective therapies and interventions.
  4. Neurorehabilitation Innovations: Innovations in neurorehabilitation techniques, including constraint-induced movement therapy, robot-assisted therapy, and virtual reality-based rehabilitation, offer promising avenues for promoting recovery and functional independence in stroke survivors, enhancing post-stroke rehabilitation outcomes and quality of life.

Recent Developments:

  1. Endovascular Thrombectomy: Endovascular thrombectomy (EVT) has emerged as a game-changing intervention for acute ischemic stroke due to large vessel occlusion, enabling rapid removal of blood clots from the cerebral vasculature and restoration of blood flow to the ischemic brain tissue, leading to improved functional outcomes and reduced disability in eligible patients.
  2. Neuroprotective Therapies: Research into neuroprotective therapies aims to mitigate brain injury and improve outcomes in acute stroke by preserving neuronal function, reducing inflammation, and preventing secondary brain damage. Novel neuroprotective agents and treatment strategies hold promise for enhancing acute stroke care and minimizing long-term disability.
  3. Telestroke and Telemedicine: Telestroke programs leverage telemedicine technology to provide timely stroke evaluation and treatment recommendations to remote or underserved areas, facilitating rapid access to specialized stroke care and improving stroke outcomes in regions with limited access to stroke centers or neurologists.
  4. Regenerative Medicine: Regenerative medicine approaches, such as stem cell therapy and growth factor administration, offer potential therapeutic benefits in stroke recovery by promoting neurogenesis, angiogenesis, and tissue repair in the damaged brain, fostering neural regeneration and functional recovery in stroke survivors.

Market Segmentation –

Type Ischemic Stroke

 

Hemorrhagic Stroke

Drug Class Tissue Plasminogen Activators (tPA)

 

Anticoagulants

Antiplatelets

Anticonvulsants

Others

Distribution Channel Hospital Pharmacies

 

Retail Pharmacies

Online Pharmacies

This Report lets you identify the opportunities in Stroke Treatment Market by means of a region:

  • North America (the United States, Canada, and Mexico)
  • Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
  • Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))
  • South America (Brazil etc.) The Middle East and Africa (North Africa and GCC Countries)

Contact Us

Transparency Market Research Inc.

CORPORATE HEADQUARTER DOWNTOWN,

1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Site içinde arama yapın
Kategoriler
Devamını oku
Diğer
India Aquaponics Market Report: Restraint, Top Competitor |Forecast ( 2024-2032)
Aquaponics Market in India: Nurturing Sustainable Agriculture In India, where agriculture is a...
Tarafından Mane Ajay 2024-04-12 07:05:11 0 2K
Diğer
5g Mmwave Market Size To Grow At A CAGR Of 15.05% During The Forecast Period
As per the current market research conducted by the CMI Team, the global 5G mmWave...
Tarafından Trisha Jadhav 2024-06-05 10:30:37 0 2K
Sağlık
Energy as A Service (EaaS) Market 2024-2032 Size, Share, Trends, Growth Drivers and SWOT Analysis Report
The Energy as A Service (EaaS) Market continues to witness substantial growth and demand, fueled...
Tarafından Jonn Kediya 2024-04-15 15:27:20 0 3K